Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Lidocaine for LMA Insertion in Pediatric Patients
NCT07562308Completed
- Sponsor
- Assiut University
- Start
- May 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine (2 arms), sponsored by Assiut University. Primary endpoint: First-attempt insertion success rate. Started May 2026; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT07562308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07562308.